BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MTCP1, C6_1B, 4515, ENSG00000214827, GS1-273L24_4 AND Diagnosis
8075 results:

  • 1. Outcomes of Y90 Radioembolization for Hepatocellular Carcinoma in Patients Previously Treated with Transarterial Embolization.
    Zhao K; Son S; Karimi A; Marinelli B; Erinjeri JP; Alexander ES; Sotirchos VS; Harding JJ; Soares KC; Ziv E; Covey A; Sofocleous CT; Yarmohammadi H
    Curr Oncol; 2024 May; 31(5):2650-2661. PubMed ID: 38785481
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Drug screening on digital microfluidics for cancer precision medicine.
    Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
    Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Impact of an Automated Population-Level Cirrhosis Screening Program Using Common Pathology Tests on Rates of Cirrhosis diagnosis and Linkage to Specialist Care (CAPRISE): Protocol for a Pilot Prospective Single-Arm Intervention Study.
    Flores JE; Trambas C; Jovanovic N; Thompson AJ; Howell J
    JMIR Res Protoc; 2024 May; 13():e56607. PubMed ID: 38776541
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ultrasound-guided percutaneous biopsy for focal liver lesions: Adverse events and diagnostic yield in a single-centre analysis.
    Pöschel T; Blank V; Schlosser T; Lingscheidt T; Böhlig A; Wiegand J; Karlas T
    PLoS One; 2024; 19(5):e0304026. PubMed ID: 38776359
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluating the diagnostic accuracy of heat shock proteins and their combination with Alpha-Fetoprotein in the detection of hepatocellular carcinoma: a meta-analysis.
    Xiang D; Fu L; Yang Y; Liu C; He Y
    BMC Gastroenterol; 2024 May; 24(1):178. PubMed ID: 38773451
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort study.
    Guo DZ; Huang A; Wang YC; Zhou S; Wang H; Xing XL; Zhang SY; Cheng JW; Xie KH; Yang QC; Ma CC; Li Q; Chen Y; Su ZX; Fan J; Liu R; Liu XL; Zhou J; Yang XR
    Clin Transl Med; 2024 May; 14(5):e1652. PubMed ID: 38741204
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
    Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
    PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Improvements in advanced hepatocellular carcinoma to repeat implementation of primary protocol after cancer progression occurs following sequential systemic therapy and a clinical trial: A case report.
    Huang H; Wei Q; Leng C; Wang H; Mei B
    Medicine (Baltimore); 2024 May; 103(19):e38138. PubMed ID: 38728500
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Applications of Pyrrole and Pyridine-based Heterocycles in cancer diagnosis and Treatment.
    Tyagi R; Yadav K; Srivastava N; Sagar R
    Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A case study of a liver transplant-treated patient with glycogen storage disease type Ia presenting with multiple inflammatory hepatic adenomas: an analysis of clinicopathologic and genetic data.
    Wang A; Wu J; Yuan X; Liu J; Lu C
    BMC Med Genomics; 2024 May; 17(1):124. PubMed ID: 38711024
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry.
    Klomberg RCW; Hellendoorn AE; Kemos P; Rizopoulos D; Ruemmele FM; Croft NM; de Ridder L;
    Lancet Child Adolesc Health; 2024 Jun; 8(6):422-432. PubMed ID: 38697175
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of the diagnosis of metabolic dysfunction-associated fatty liver disease and non-alcoholic fatty liver disease in patients undergoing liver transplantation for hepatocellular carcinoma.
    Zhu JQ; Liu JZ; Yang SW; Ren ZY; Ye XY; Liu Z; Li XL; Han DD; He Q
    Front Endocrinol (Lausanne); 2024; 15():1306091. PubMed ID: 38686208
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Phenotype and Disease Course of Inflammatory Bowel Disease in Iran: Results of the Iranian Registry of Crohn's and Colitis (IRCC).
    Saberzadeh-Ardestani B; Khosravi AA; Mansour-Ghanaei F; Vahedi H; Baniasadi N; Seyyedmajidi M; Parhizkar B; Hormati A; Naghshbandi SJ; Matin S; Hassan Zadeh AA; Taghvaei T; Bahrami M; Rafeey M; Ahadi M; Vossoughinia H; Muosavi H; Gheibi S; Hosseini-Hemmatabadi RS; Yazdanbod A; Matinkhah S; Sheikh Esmaeili F; Fakheri H; Moosavy SH; Maleki I; Nasseri-Moghaddam S; Khosravi B; Farahmand F; Najafi M; Alimadadi H; Malekzadeh M; Anushiravani A; Kasaeian A; Alatab S; Sadeghi A; Radmard AR; Kolahdoozan S; Rajabi Z; Sima AR
    Arch Iran Med; 2024 Apr; 27(4):183-190. PubMed ID: 38685844
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
    Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
    JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Primary hepatic sarcomatoid carcinoma, an unusual case].
    Rueda DA; Antinucci F; Amante MF; Bas CA
    Medicina (B Aires); 2024; 84(2):337-341. PubMed ID: 38683520
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
    Öztürk NB; Jamil LH
    Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.
    Tajima T; Martinez OM; Bernstein D; Boyd SD; Gratzinger D; Lum G; Sasaki K; Tan B; Twist CJ; Weinberg K; Armstrong B; Desai DM; Mazariegos GV; Chin C; Fishbein TM; Tekin A; Venick RS; Krams SM; Esquivel CO
    Pediatr Transplant; 2024 Jun; 28(4):e14763. PubMed ID: 38682750
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluation of Circular RNA SMARCA5 as a Novel Biomarker for Hepatocellular Carcinoma.
    Bedair HM; El-Banna EA; Ahmed EA; Elhelbawy MG; Abdelfattah A; Khalaf FA; Abdel-Samiee M; El Sharnoby A
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1411-1417. PubMed ID: 38680002
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 404.